-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $38

Benzinga·08/25/2026 17:05:58
Listen to the news
Deutsche Bank analyst David Hoang maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $37 to $38.